Skip to main content
Top
Published in: BMC Urology 1/2019

Open Access 01-12-2019 | Research article

The unveiling of a new risk factor associated with bladder cancer in Lebanon

Authors: Sally Temraz, Yolla Haibe, Maya Charafeddine, Omran Saifi, Deborah Mukherji, Ali Shamseddine

Published in: BMC Urology | Issue 1/2019

Login to get access

Abstract

Background

No accurate evaluation of smoking and water pollution on bladder cancer has been conducted in the Lebanese population. Our aim is to examine the significance of smoking and one of the main water pollutants Trihalomethanes (THM) on bladder cancer risk.

Methods

Population Attributable Fraction (PAF) was used to quantify the contribution of the risk factors smoking and THMs on bladder cancer in Lebanon. To calculate PAF for each risk factor, we used the proportion of the population exposed and the relative risk for each risk factor. Relative risks for each risk factor were obtained from published meta-analyses. The population at risk values were obtained from a report on chronic disease risk factor surveillance in Lebanon which was conducted by the World Health Organization between 2008 and 2009 and a national study by Semerjian et al. that conducted a multipathway exposure assessment of selected public drinking waters of Lebanon for the risk factors smoking and THMs, respectively.

Results

Bladder cancer cases that were the result of smoking in Lebanon among males and females are 33.4 and 18.6%, respectively. Cases attributed to mid-term exposure to THM contamination of drinking water is estimated at 8.6%.

Conclusion

This paper further highlights the negative impact of smoking on bladder cancer risk and adds an overlooked and often underestimated risk that THMs have on this type of cancer. Thus, it is imperative that a national based study which assesses THM exposure by gender and smoking status be implemented to determine the real risk behind this byproduct.
Literature
1.
go back to reference Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86.CrossRef Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86.CrossRef
2.
go back to reference Jankovic S, Radosavljevic V. Risk factors for bladder cancer. Tumori. 2007;93:4–12.CrossRef Jankovic S, Radosavljevic V. Risk factors for bladder cancer. Tumori. 2007;93:4–12.CrossRef
3.
go back to reference Malats N, Real FX. Epidemiology of bladder cancer. Hematol Oncol Clin North Am. 2015;29:177–89 vii.CrossRef Malats N, Real FX. Epidemiology of bladder cancer. Hematol Oncol Clin North Am. 2015;29:177–89 vii.CrossRef
4.
go back to reference IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Personal Habits and Indoor Combustions, vol. 100. E. Lyon, France: International Agency for Research on Cancer; 2012. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Personal Habits and Indoor Combustions, vol. 100. E. Lyon, France: International Agency for Research on Cancer; 2012.
5.
go back to reference Bjerregaard BK, Raaschou-Nielsen O, Sorensen M, Frederiksen K, Christensen J, Tjonneland A, et al. Tobacco smoke and bladder cancer--in the European prospective investigation into Cancer and nutrition. Int J Cancer. 2006;119:2412–6.CrossRef Bjerregaard BK, Raaschou-Nielsen O, Sorensen M, Frederiksen K, Christensen J, Tjonneland A, et al. Tobacco smoke and bladder cancer--in the European prospective investigation into Cancer and nutrition. Int J Cancer. 2006;119:2412–6.CrossRef
6.
go back to reference Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC. Association between smoking and risk of bladder cancer among men and women. JAMA. 2011;306:737–45.CrossRef Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC. Association between smoking and risk of bladder cancer among men and women. JAMA. 2011;306:737–45.CrossRef
7.
go back to reference Morris RD. Drinking water and cancer. Environ Health Perspect. 1995;103(Suppl 8):225–31.CrossRef Morris RD. Drinking water and cancer. Environ Health Perspect. 1995;103(Suppl 8):225–31.CrossRef
8.
go back to reference Cantor KP. Drinking water and cancer. Cancer Causes Control. 1997;8:292–308.CrossRef Cantor KP. Drinking water and cancer. Cancer Causes Control. 1997;8:292–308.CrossRef
9.
go back to reference Villanueva C, Fernandez F, Malats N, Grimalt J, Kogevinas M. Meta-analysis of studies on individual consumption of chlorinated drinking water and bladder cancer. J Epidemiol Community Health. 2003;57:166–73.CrossRef Villanueva C, Fernandez F, Malats N, Grimalt J, Kogevinas M. Meta-analysis of studies on individual consumption of chlorinated drinking water and bladder cancer. J Epidemiol Community Health. 2003;57:166–73.CrossRef
10.
go back to reference Costet N, Villanueva CM, Jaakkola JJ, Kogevinas M, Cantor KP, King WD, et al. Water disinfection by-products and bladder cancer: is there a European specificity? A pooled and meta-analysis of European case-control studies. Occup Environ Med. 2011;68:379–85.CrossRef Costet N, Villanueva CM, Jaakkola JJ, Kogevinas M, Cantor KP, King WD, et al. Water disinfection by-products and bladder cancer: is there a European specificity? A pooled and meta-analysis of European case-control studies. Occup Environ Med. 2011;68:379–85.CrossRef
11.
go back to reference Cantor KP, Lynch CF, Hildesheim ME, Dosemeci M, Lubin J, Alavanja M, et al. Drinking water source and chlorination byproducts. I. Risk of bladder cancer. Epidemiology. 1998;9:21–8.CrossRef Cantor KP, Lynch CF, Hildesheim ME, Dosemeci M, Lubin J, Alavanja M, et al. Drinking water source and chlorination byproducts. I. Risk of bladder cancer. Epidemiology. 1998;9:21–8.CrossRef
12.
go back to reference King WD, Marrett LD. Case-control study of bladder cancer and chlorination by-products in treated water (Ontario, Canada). Cancer Causes Control. 1996;7:596–604.CrossRef King WD, Marrett LD. Case-control study of bladder cancer and chlorination by-products in treated water (Ontario, Canada). Cancer Causes Control. 1996;7:596–604.CrossRef
13.
go back to reference Bove GE Jr, Rogerson PA, Vena JE. Case-control study of the effects of trihalomethanes on urinary bladder cancer risk. Arch Environ Occup Health. 2007;62:39–47.CrossRef Bove GE Jr, Rogerson PA, Vena JE. Case-control study of the effects of trihalomethanes on urinary bladder cancer risk. Arch Environ Occup Health. 2007;62:39–47.CrossRef
14.
go back to reference Beane Freeman LE, Cantor KP, Baris D, Nuckols JR, Johnson A, Colt JS, et al. Bladder Cancer and water disinfection by-product exposures through multiple routes: a population-based case-control study (New England, USA). Environ Health Perspect. 2017;125:067010.CrossRef Beane Freeman LE, Cantor KP, Baris D, Nuckols JR, Johnson A, Colt JS, et al. Bladder Cancer and water disinfection by-product exposures through multiple routes: a population-based case-control study (New England, USA). Environ Health Perspect. 2017;125:067010.CrossRef
15.
go back to reference Amado RG, Wolf M, Peeters M, Van Cutsem E, Siena S, Freeman DJ, et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol. 2008;26:1626–34.CrossRef Amado RG, Wolf M, Peeters M, Van Cutsem E, Siena S, Freeman DJ, et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol. 2008;26:1626–34.CrossRef
16.
go back to reference Villanueva CM, Cantor KP, Grimalt JO, Malats N, Silverman D, Tardon A, et al. Bladder cancer and exposure to water disinfection by-products through ingestion, bathing, showering, and swimming in pools. Am J Epidemiol. 2007;165:148–56.CrossRef Villanueva CM, Cantor KP, Grimalt JO, Malats N, Silverman D, Tardon A, et al. Bladder cancer and exposure to water disinfection by-products through ingestion, bathing, showering, and swimming in pools. Am J Epidemiol. 2007;165:148–56.CrossRef
17.
go back to reference Shamseddine A, Saleh A, Charafeddine M, Seoud M, Mukherji D, Temraz S, et al. Cancer trends in Lebanon: a review of incidence rates for the period of 2003-2008 and projections until 2018. Popul Health Metrics. 2014;12:4.CrossRef Shamseddine A, Saleh A, Charafeddine M, Seoud M, Mukherji D, Temraz S, et al. Cancer trends in Lebanon: a review of incidence rates for the period of 2003-2008 and projections until 2018. Popul Health Metrics. 2014;12:4.CrossRef
18.
go back to reference Parkin DM, Boyd L, Walker LC. 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer. 2011;105(Suppl 2):S77–81.CrossRef Parkin DM, Boyd L, Walker LC. 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer. 2011;105(Suppl 2):S77–81.CrossRef
19.
go back to reference Sibai A, Hwala N: WHO steps chronic disease risk factor surveillance: data book for Lebanon, 2009. American University of Beirut; 2010. Sibai A, Hwala N: WHO steps chronic disease risk factor surveillance: data book for Lebanon, 2009. American University of Beirut; 2010.
20.
go back to reference Semerjian L, Dennis J. Multipathway risk assessment of trihalomethane exposure in drinking water of Lebanon. J Water Health. 2007;5:511–22.CrossRef Semerjian L, Dennis J. Multipathway risk assessment of trihalomethane exposure in drinking water of Lebanon. J Water Health. 2007;5:511–22.CrossRef
21.
go back to reference Semerjian LA. Quality assessment of various bottled waters marketed in Lebanon. Environ Monit Assess. 2011;172:275–85.CrossRef Semerjian LA. Quality assessment of various bottled waters marketed in Lebanon. Environ Monit Assess. 2011;172:275–85.CrossRef
22.
go back to reference Park S, Jee SH, Shin HR, Park EH, Shin A, Jung KW, et al. Attributable fraction of tobacco smoking on cancer using population-based nationwide cancer incidence and mortality data in Korea. BMC Cancer. 2014;14:406.CrossRef Park S, Jee SH, Shin HR, Park EH, Shin A, Jung KW, et al. Attributable fraction of tobacco smoking on cancer using population-based nationwide cancer incidence and mortality data in Korea. BMC Cancer. 2014;14:406.CrossRef
23.
go back to reference Hanley JA. A heuristic approach to the formulas for population attributable fraction. J Epidemiol Community Health. 2001;55:508–14.CrossRef Hanley JA. A heuristic approach to the formulas for population attributable fraction. J Epidemiol Community Health. 2001;55:508–14.CrossRef
24.
go back to reference Saade G, Warren CW, Jones NR, Asma S, Mokdad A. Linking global youth tobacco survey (GYTS) data to the WHO framework convention on tobacco control (FCTC): the case for Lebanon. Prev Med. 2008;47(Suppl 1):S15–9.CrossRef Saade G, Warren CW, Jones NR, Asma S, Mokdad A. Linking global youth tobacco survey (GYTS) data to the WHO framework convention on tobacco control (FCTC): the case for Lebanon. Prev Med. 2008;47(Suppl 1):S15–9.CrossRef
25.
go back to reference Shamseddine A, Sibai AM, Gehchan N, Rahal B, El-Saghir N, Ghosn M, et al. Cancer incidence in postwar Lebanon: findings from the first national population-based registry, 1998. Ann Epidemiol. 2004;14:663–8.CrossRef Shamseddine A, Sibai AM, Gehchan N, Rahal B, El-Saghir N, Ghosn M, et al. Cancer incidence in postwar Lebanon: findings from the first national population-based registry, 1998. Ann Epidemiol. 2004;14:663–8.CrossRef
26.
go back to reference Kulhanova I, Bray F, Fadhil I, Al-Zahrani AS, El-Basmy A, Anwar WA, et al. Profile of cancer in the eastern Mediterranean region: the need for action. Cancer Epidemiol. 2017;47:125–32.CrossRef Kulhanova I, Bray F, Fadhil I, Al-Zahrani AS, El-Basmy A, Anwar WA, et al. Profile of cancer in the eastern Mediterranean region: the need for action. Cancer Epidemiol. 2017;47:125–32.CrossRef
27.
go back to reference Villanueva CM, Cantor KP, Cordier S, Jaakkola JJ, King WD, Lynch CF, et al. Disinfection byproducts and bladder cancer: a pooled analysis. Epidemiology. 2004;15:357–67.CrossRef Villanueva CM, Cantor KP, Cordier S, Jaakkola JJ, King WD, Lynch CF, et al. Disinfection byproducts and bladder cancer: a pooled analysis. Epidemiology. 2004;15:357–67.CrossRef
28.
go back to reference Villanueva CM, Cantor KP, Grimalt JO, Castano-Vinyals G, Malats N, Silverman D, et al. Assessment of lifetime exposure to trihalomethanes through different routes. Occup Environ Med. 2006;63:273–7.CrossRef Villanueva CM, Cantor KP, Grimalt JO, Castano-Vinyals G, Malats N, Silverman D, et al. Assessment of lifetime exposure to trihalomethanes through different routes. Occup Environ Med. 2006;63:273–7.CrossRef
Metadata
Title
The unveiling of a new risk factor associated with bladder cancer in Lebanon
Authors
Sally Temraz
Yolla Haibe
Maya Charafeddine
Omran Saifi
Deborah Mukherji
Ali Shamseddine
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Urology / Issue 1/2019
Electronic ISSN: 1471-2490
DOI
https://doi.org/10.1186/s12894-019-0445-9

Other articles of this Issue 1/2019

BMC Urology 1/2019 Go to the issue